上海医药2024,Vol.45Issue(1) :60-64.

典型国家或地区药品医保支付标准制定方法的国际经验及启示

International experience and enlightenment of the formulation method of drug medical insurance payment standard in typical countries or regions

聂浩淼 陈怡娜 张珂 周明 柳鹏程
上海医药2024,Vol.45Issue(1) :60-64.

典型国家或地区药品医保支付标准制定方法的国际经验及启示

International experience and enlightenment of the formulation method of drug medical insurance payment standard in typical countries or regions

聂浩淼 1陈怡娜 1张珂 1周明 1柳鹏程1
扫码查看

作者信息

  • 1. 中国药科大学国际医药商学院 南京 211198
  • 折叠

摘要

目的:为丰富和完善我国药品医疗保障基金支付(以下简称医保支付)标准制定方法提供参考.方法:通过系统梳理德国、英国、日本和中国台湾地区药品医保支付标准制定方法的政策文件和相关文献,总结其共性和特色.结果:德国采取参考价格制度和新药定价机制;英国采用以价值为基础的定价方式;日本采取新药创新性加价、仿制药递减定价法;中国台湾地区则对药品分类分组进而差别定价.结论:德国、英国、日本和中国台湾地区均对药品进行分类,创新药主要依照临床价值及成本进行定价,非创新药主要依照竞争递减比例以及参考药价的方式定价,我国在丰富和完善药品医保支付标准制定方法时可有所借鉴.

Abstract

Objective:To provide reference for enriching and improving the formulation method of drug medical insurance payment standards in China.Methods:Through systematically sorting the policy documents and relevant literature on the standard formulation methods of drug medical insurance payment in Germany,the United Kingdom,Japan and Taiwan of China,their commonalities and characteristics were summarized.Results:A reference price system and a new drug pricing mechanism are adopted in Germany,a value-based pricing approach in the UK,the innovative price increase of new drugs and the decreasing pricing method of generic drugs in Japan while drugs are first grouped and then differently priced in Taiwan region.Conclusion:Drugs are all classified in those countries and region.Innovative drugs are mainly priced according to clinical value and cost,and non-innovative drugs are mainly priced according to the decreasing proportion of competition and reference drug prices,which can be used as reference for our country in enriching and perfecting the method for formulating the standard of payment for medicines in the medical insurance.

关键词

医药改革/国际经验/支付标准

Key words

pharmaceutical reform/international experience/payment standard

引用本文复制引用

出版年

2024
上海医药
上海医药行业协会

上海医药

影响因子:0.781
ISSN:1006-1533
参考文献量8
段落导航相关论文